Artificiële Intelligentie & Recht
Innovation, Quantum-AI Technology & Law
0

Blog over Kunstmatige Intelligentie, Quantum, Deep Learning, Blockchain en Big Data Law

Blog over juridische, sociale, ethische en policy aspecten van Kunstmatige Intelligentie, Quantum Computing, Sensing & Communication, Augmented Reality en Robotica, Big Data Wetgeving en Machine Learning Regelgeving. Kennisartikelen inzake de EU AI Act, de Data Governance Act, cloud computing, algoritmes, privacy, virtual reality, blockchain, robotlaw, smart contracts, informatierecht, ICT contracten, online platforms, apps en tools. Europese regels, auteursrecht, chipsrecht, databankrechten en juridische diensten AI recht.

Berichten met de tag Hippocratic Quantum
BioLawLaPaLooZa: Mauritz Kop on Hippocratic Quantum and the End of Stable Records at Stanford Law School
BioLawLaPaLooZa: Mauritz Kop on Hippocratic Quantum and the End of Stable Records at Stanford Law School

At BioLawLaPaLooZa, the annual law-and-biosciences conference convened at Stanford Law School by Henry T. "Hank" Greely and co-hosted with the Journal of Law and the Biosciences, Mauritz Kop delivered a talk that fused two strands of his recent work: the biomedical-ethics argument of his Harvard-published Hippocratic Quantum project and the security lens of his NATO Strategic Communications advisory work. It was his third appearance at the gathering, which builds on his earlier BioLawLaPaLooZa remarks.

The past is not yet stable

Kop's organizing line was that "the past is not yet stable." Rather than treating the quantum threat as a future event, he argued that today's authenticated, confidential records are contingent on a cryptographic transition still under way: adversaries can harvest encrypted data now and decrypt it once a Shor-capable machine factors the large integers beneath RSA. Confidentiality, in this reading, must be defended retroactively as well as prospectively—making the migration to post-quantum cryptography, for hospitals and biobanks, a clinical duty rather than an IT preference. The point reframes a familiar threat model: the danger is not only what a future machine will decrypt, but what is being copied and stored today against that day.

Four classical principles, recomputed

The talk recast the four principles of biomedical ethics—autonomy, beneficence, non-maleficence, and justice—for a quantum register. Quantum does not replace them, Kop said; it changes what applying them requires. Autonomy comes to demand data sovereignty and a credible right not to know as quantum-AI systems build finer probabilistic patient models. Dual-use simulators that design therapeutics can also lower the barrier to designing pathogens, which is where his LSI test—least trade-restrictive, security-sufficient, innovation-preserving—supports tiered disclosure over blanket secrecy. And the justice problem is a widening one: the quantum divide, he warned, may prove steeper than the digital divide.

The X-Ray City and a constitution for medicine

Widening the lens, Kop described civic-scale quantum gravimetric and magnetic sensors moving from the laboratory toward infrastructure pilots—able, from public rights-of-way, to resolve subsurface and interior spaces, and so to reach into the privacy of the home. He calls this prospect the X-Ray City, and said he had told NATO it needs a Hippocratic Quantum posture of its own. He closed with a "quantum constitution for medicine" in four standards of care: quantum-safe encryption, sovereignty over patient digital twins, human oversight in the loop, and tiered disclosure under the LSI test. The premise the room had not heard before, he suggested, was simply that the past itself is not yet settled.

Meer lezen
Academics, Healthcare, Stanford RQTHenry QuentirMauritz Kop, Stanford RQT, Healthcare, Ethics, Quantum Governance, Quantum Technology, Stanford Law School, Hippocratic Quantum, BioLawLapalooza, Hank Greely, Post-Quantum Cryptography, LSI Test, Quantum-AI, Petrie-Flom Center
Mauritz Kop Consults Amgen on Quantum-Biomedical Discovery
Mauritz Kop Consults Amgen on Quantum-Biomedical Discovery

Invited by Howard Chang—the physician-scientist who led a renowned genomics laboratory at Stanford and now serves as Senior Vice President, Global Research, and Chief Scientific Officer at Amgen—Mauritz Kop consulted with Amgen's research organization on quantum-biomedical discovery: a disciplined exchange of ideas about where quantum methods can genuinely improve the way medicines are found.

An invitation from Amgen's chief scientist

The conversation paired deep biology with quantum strategy and governance. Its anchor was the Hippocratic Quantum approach Kop published at Harvard: accelerate discovery with quantum and quantum-classical methods, but under guardrails medicine itself would prescribe—validation, privacy, security, and patient trust from the first experiment. The same translational seriousness ran through the responsible-quantum lecture and workshop Kop gave at SandboxAQ.

Six use cases, one discipline

From computational chemistry for de novo discovery and lead optimization, through protein structure and selected omics analytics, metabolism and toxicity simulation, blood-brain-barrier hypotheses validated in organoid and lab-on-a-chip systems, operational optimization, and a watchlist for quantum neural networks—every candidate use case answers to the same rule: benchmark hard against strong classical baselines from day one, and let the evidence decide which pilots earn the next dollar.

Guardrails before hype

The strategy's quiet half is security and governance: a post-quantum cryptography roadmap for long-lived patient and research data, vendor diversification across qubit modalities, trade-secret and IP protection, and standards alignment. What the exchange was about, in the end, is decision quality—smarter discovery pipelines, better-protected data, and medicines that reach patients sooner.

Meer lezen
Healthcare, Quantum Technology, MedicineHenry QuentirMauritz Kop, Stanford RQT, Quantum Governance, Healthcare, Post-Quantum Cryptography, Amgen, Hippocratic Quantum, Quantum Medicine, Drug Discovery, Biomedical Discovery
Harvard Law Publishes Hippocratic Quantum: The Ethics of Biomedical Discovery in the Quantum Age
Harvard Law Publishes Hippocratic Quantum: The Ethics of Biomedical Discovery in the Quantum Age

Cambridge, MA, February 25, 2026—Harvard Law’s Petrie-Flom Center has published Mauritz Kop’s new article, Hippocratic Quantum: The Ethics of Biomedical Discovery in the Quantum Age:https://petrieflom.law.harvard.edu/2026/02/25/hippocratic-quantum-the-ethics-of-biomedical-discovery-in-the-quantum-age/

The article advances a proposition that is becoming increasingly difficult for health lawyers, policymakers, and biomedical innovators to ignore: as quantum technologies begin to enter biomedical discovery, the decisive challenge is no longer only scientific capability, but rather governance. In Kop’s account, quantum-enabled medicine should not be understood as a distant or speculative frontier that can be regulated later, once the engineering settles. It should instead be approached as a present-tense quantum governance problem, one that already implicates patient confidentiality, data integrity, cyber resilience, export controls, supply chains, and the geostrategic value of biomedical knowledge.

The article’s answer is not a new morality, but a more demanding implementation of an existing one: quantum medicine requires a Hippocratic framework that is technical enough for engineers, legal enough for regulators, and concrete enough for hospitals and pharmaceutical firms, yet flexible enough to let innovation breathe and encourage the crucial public-private investment necessary to advance allied quantum capabilities.

Five examples of quantum-enabled biomedical innovations

To ground this institutional view, one must consider the specific technological capabilities currently transitioning from theoretical physics to applied biomedicine. Five feasible vectors of innovation illustrate the breadth of this shift. In the domain of quantum computing, hybrid classical-quantum algorithms are emerging to optimize complex drug discovery pipelines and process large-scale genomic datasets. In quantum sensing, technologies such as diamond nitrogen-vacancy magnetometry enable ultra-sensitive, room-temperature mapping of neurological and cardiac activity. For quantum simulation, researchers are utilizing qubit-based systems to model molecular interactions and drug-target binding affinities with high accuracy, aiming to reduce reliance on extensive physical wet-lab screening. Within quantum imaging, techniques leveraging entangled photons permit the high-resolution visualization of cellular structures at lower light intensities, thereby mitigating phototoxicity in living tissues, benefitting medical diagnosis. Finally, in quantum networking, the deployment of quantum key distribution protocols offers a mechanism to cryptographically secure the transmission of sensitive multi-omics data across distributed hospital and research architectures.

From legal-ethical framework to Quantum-ELSPI

The Harvard article is best read as part of a longer intellectual trajectory. An early expression of that project appeared in March 2021 in the Yale Journal of Law & Technology, in Establishing a Legal-Ethical Framework for Quantum Technology: https://yjolt.org/blog/establishing-legal-ethical-framework-quantum-technology

That Yale piece argued that quantum technologies were moving from hypothetical ideas to commercial realities, and that law and policy should not wait for full technical maturity before building governance tools. It proposed a culturally sensitive legal-ethical framework for applied quantum technologies, drawing on AI governance and nanotechnology’s ELSI tradition while recognizing the distinct physical characteristics of quantum systems. Crucially, it also insisted that ethical aspiration must be accompanied by practical mechanisms for monitoring, validation, and life-cycle risk management. In retrospect, many of the themes that now reappear in Hippocratic Quantum were already visible there: the concern for human-centered design, the call for risk-based governance, and the insistence that ethics without institutionalization would be inadequate.

Why quantum medicine changes the governance question

The new Harvard article narrows the focus to biomedicine, but in doing so it sharpens the stakes. Biomedical discovery is not simply another application area. It is a setting in which long-lived and highly sensitive data, bodily integrity, public-health interests, commercial incentives, and geopolitical competition intersect. Quantum technologies matter here not because they promise speculative disruption, but because they may incrementally and then materially improve specific tasks: hybrid quantum-classical computational chemistry, de novo molecular design, lead optimization, selected toxicity and metabolism modeling, and perhaps aspects of high-fidelity sensing, simulation, and networked quantum computation. The issue, then, is not whether every promise will be realized immediately. It is whether institutions are preparing now for the forms of capability that are already foreseeable.

A Harvard-facing research arc

This Harvard publication also extends a longer Harvard-facing research arc across AI, health law, and responsible quantum governance. That arc includes:

  1. The Right To Process Data For Machine Learning Purposes In The EU (Harvard JOLT) https://jolt.law.harvard.edu/digest/the-right-to-process-data-for-machine-learning-purposes-in-the-eu

  2. Towards Responsible Quantum Technology (Harvard Berkman Klein) https://cyber.harvard.edu/publication/2023/towards-responsible-quantum-technology

  3. EU And US Regulatory Challenges Facing AI Health Care Innovator Firms (Harvard Petrie-Flom) https://petrieflom.law.harvard.edu/2024/04/04/eu-and-us-regulatory-challenges-facing-ai-health-care-innovator-firms/

  4. A Brief Quantum Medicine Policy Guide (Harvard Petrie-Flom) https://petrieflom.law.harvard.edu/2024/12/06/a-brief-quantum-medicine-policy-guide/

  5. How Quantum Technologies May Be Integrated Into Healthcare: What Regulators Should Consider (Stanford Law) https://hls.harvard.edu/bibliography/how-quantum-technologies-may-be-integrated-into-healthcare-what-regulators-should-consider/

Seen in this broader context, Hippocratic Quantum brings together early legal-ethical framing, responsible quantum governance, healthcare regulation, and geopolitical analysis into a single biomedical governance argument.

The article has also been featured by The Quantum Insider, which highlighted its central argument that quantum medicine’s promise must be matched by stronger privacy and governance safeguards: https://thequantuminsider.com/2026/02/27/analysis-quantum-medicines-promise-raises-new-privacy-and-governance-risks/

Meer lezen
Ethics, Governance, Geopolitics, Medical Devices, Medicine, Harvard, Healthcare, Quantum Computing, Quantum ELSPI, Quantum Sensing, Quantum Technology, Quantum-AIMauritz KopEthics, Quantum, Law, Governance, Biomedical Innovation, Harvard, Hippocratic Quantum, Mauritz Kop